A Study of Hydroxychloroquine in Combination With Gemcitabine/Abraxane in Pancreatic Cancer

Clinical trial NCT01506973 · COMPLETED

Trial details

NCT number: NCT01506973
Sponsor: Abramson Cancer Center at Penn Medicine
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Adenocarcinoma Metastatic Adenocarcinoma

Start date: 2011-12-01
Primary completion: 2022-03-01
Enrollment: 119

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.